When to Add Bevacizumab for Recurrent Ovarian Cancer

Advances in Immunotherapy in Ovarian CancerПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

3/26/2021: Upfront Treatment of Advanced Ovarian Cancer; Ay, Now the Plot ThickensПодробнее

Strategies for Managing Recurrent Ovarian CancerПодробнее

Dr. Mirza on Efficacy of Niraparib/Bevacizumab Combo in Recurrent Ovarian CancerПодробнее

Recurrent Ovarian Cancer: Selecting Second-Line TherapyПодробнее

Bevacizumab in Recurrent Ovarian CancerПодробнее

Ovarian Cancer: Therapeutic Management at RecurrenceПодробнее

Bevacizumab for Recurrent Ovarian CancerПодробнее

Dr. Krishnansu Tewari: Ovarian Cancers- Epithelial Tumors of the PelvisПодробнее

Ovarian Cancer - Dr. Laura HavrileskyПодробнее

Ovarian Cancer: Standards of Care and New Opportunities - Dr. Robert ColemanПодробнее

NOCC's Ovarian Cancer Education Series - Dealing with RecurrenceПодробнее